<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Comparison of typical clinical features and specific management of disorders associated with a platelet count &lt;80,000/microL occurring after 20 weeks gestation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Comparison of typical clinical features and specific management of disorders associated with a platelet count &lt;80,000/microL occurring after 20 weeks gestation</h1>
<div class="graphic"><div class="figure"><div class="ttl">Comparison of typical clinical features and specific management of disorders associated with a platelet count &lt;80,000/microL occurring after 20 weeks gestation</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Clinical feature</td> <td class="subtitle1">Preeclampsia/HELLP</td> <td class="subtitle1">TTP</td> <td class="subtitle1">C-TMA</td> <td class="subtitle1">ITP</td> <td class="subtitle1">Hemorrhage/DIC</td> <td class="subtitle1">Sepsis/DIC</td> </tr> <tr class="divider_bottom"> <td>Incidence</td> <td>100 in 10,000 pregnancies</td> <td>1 in 10,000 pregnancies</td> <td>Unknown. May be similar to TTP.</td> <td>3 in 10,000 pregnancies</td> <td>2 in 10,000 pregnancies</td> <td>1 in 10,000 pregnancies</td> </tr> <tr class="divider_bottom"> <td>Time of occurrence</td> <td>By definition, occurs after 20 weeks of gestation; more common near term and within three days postpartum</td> <td>May occur throughout pregnancy, but most common near term and several weeks postpartum</td> <td>May occur throughout pregnancy, but most common postpartum</td> <td>Any time during pregnancy</td> <td>Most commonly at delivery and postpartum</td> <td>Most commonly at delivery and postpartum</td> </tr> <tr class="divider_bottom"> <td>Vital signs</td> <td>Hypertension, by definition, BP â‰¥160/110</td> <td>Normal BP, fever may be present but is rare</td> <td>Hypertension due to AKI</td> <td>Normal, unless hypotension and tachycardia from bleeding</td> <td>Hypotension, tachycardia (may have been transient)</td> <td>Fever, hypotension, tachycardia</td> </tr> <tr class="divider_bottom"> <td>Neurologic abnormalities</td> <td>Headache, vision changes. Less commonly eclamptic seizures, PRES, stroke.</td> <td>Severe in 41% (transient focal defects, seizure, stroke); minor in 30%</td> <td>None</td> <td>None</td> <td>Probably none</td> <td>Probably none</td> </tr> <tr class="divider_bottom"> <td>Microangiopathic hemolysis/schistocytes</td> <td>Moderate</td> <td>Severe</td> <td>Moderate</td> <td>None</td> <td>Variable</td> <td>Variable</td> </tr> <tr class="divider_bottom"> <td>Kidney injury</td> <td>Usually mild, but severe AKI is possible. Dialysis is rarely required.</td> <td>Usually mild or absent; severe AKI requiring dialysis in &lt;5%</td> <td>Severe, typically dialysis is required</td> <td>None</td> <td>Severe ATN, reversible</td> <td>May have ATN, reversible</td> </tr> <tr class="divider_bottom"> <td>Liver function tests: ALT, AST</td> <td>From normal to markedly increased</td> <td>Normal or slightly increased</td> <td>Normal</td> <td>Normal</td> <td>May be markedly increased</td> <td>May be increased</td> </tr> <tr class="divider_bottom"> <td>Typical course following delivery</td> <td>Stabilization or improvement within 48 hours</td> <td>No stabilization or improvement within 48 hours</td> <td>Increasing serum creatinine</td> <td>Most unchanged, but may improve after delivery</td> <td>Recovery after source of hemorrhage corrected</td> <td>Recovery after appropriate treatment</td> </tr> <tr> <td>Specific management</td> <td>Delivery of infant is curative</td> <td> <p>For immune TTP, plasma exchange and immunosuppression.</p> For hereditary TTP, plasma infusion (or other source of ADAMTS13). </td> <td>Anti-complement agent</td> <td>Glucocorticoids, IVIG, and maybe additional immunosuppressive agents and/or a thrombopoietin receptor agonist (TPO-RA) for refractory disease</td> <td>Identify and correct source of hemorrhage. May require additional laparotomy.</td> <td>Antibiotics</td> </tr> </tbody></table></div><div class="graphic_lgnd">The incidence of preeclampsia with severe features is 1 case per 100 pregnancies. The incidence of TTP during pregnancy is estimated from data from the Oklahoma TTP Registry (frequency of TTP during pregnancy), and the CDC (birth rate per population).</div><div class="graphic_footnotes">PE/HELLP: preeclampsia/hemolysis, elevated liver enzymes, low platelets; TTP: thrombotic thrombocytopenic purpura; C-TMA: complement-mediated thrombotic microangiopathy; ITP: immune thrombocytopenia; DIC: disseminated intravascular coagulation; PRES: posterior reversible encephalopathy syndrome; AKI: acute kidney injury; ATN: acute tubular necrosis; AST: aspartate aminotransferase; ALT: alanine aminotransferase; IVIG: intravenous immune globulin; CDC: US Centers for Disease Control and Prevention.</div><div class="graphic_reference">Courtesy of James N George, MD and Jennifer J McIntosh, DO, MS.</div><div id="graphicVersion">Graphic 111517 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
